Search Results 1501-1510 of 17452 for magnesiummagnesium

1. Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) - Mayo Clinic

   OCS dose no more than 0.3mg/kg/day in the 7 days before screening visit. Taking super-potent topical corticosteroids (such as clobetasol propionate ...

2. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

   ... mg/L) ≤ 5 weeks prior to registration). Symptomatic anemia is defined as ... (72)(serum creatinine in mg/dL);; Creatinine clearance for females = (140 ...

3. Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma - Mayo Clinic

   Low dose warfarin (1 mg orally, once daily) with prothrombin time (PT)-international normalized ratio (INR) =< 1.5 x ULN is permitted; infrequent bleeding ...

4. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

   ... mg/dl. Patients must have adequate renal function as evidenced by a serum creatinine of <2.0 mg/dl. Patients must have K+ >3.5 mEq/l. Patients or their ...

5. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

   Current or recent (≤ 10 days prior to randomization) use of aspirin (> 325 mg/day), clopidogrel (> 75 mg/day), or current or recent (≤ 10 days prior to ...

6. A Study to Evaluate the Effectiveness and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema in Adolescents and Adults - Mayo Clinic

   ... mg/day or equivalent high-dose second-generation antihistamine medication); ... Clinical history of not responding to high-dose antihistamine treatment ( ...

7. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

   Need for concurrent treatment for the CNS disease (e.g., surgery, radiation, corticosteroids > 10 mg prednisone/day or equivalent);; Progression of CNS ...

8. Cancer-Related Fatigue Clinical Trials - Mayo Clinic Research

   The Fucoidan dose of 400 mg formulation is specifically being made for this trial. Remote Monitoring for Lifestyle Changes in Patients with Lung Cancer ...

9. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

   > 2.5 mg/dL. Coagulation. International Normalized Ratio (INR) or Prothrombin Time (PT). ≤ 1.5 X ULN unless subject is receiving anticoagulant therapy as ...

10. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    ... mg/day) or off of all corticosteroids for at least 2 weeks before the first dose of study treatment. Prior radiotherapy within 2 weeks of study treatment ...